Enovis Corporation (LON:0I1B)

Market Cap	1.36B
Revenue (ttm)	1.61B
Net Income (ttm)	-606.62M
Shares Out	n/a
EPS (ttm)	-10.76
PE Ratio	n/a
Forward PE	10.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	674
Average Volume	507
Open	32.78
Previous Close	31.14
Day's Range	31.82 - 32.78
52-Week Range	25.72 - 49.55
Beta	n/a
RSI	57.42
Earnings Date	Nov 7, 2025

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company’s Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management,...

• Industry: Industrial - Capital Goods
• Sector: Industrials
• Founded: 1995
• Employees: 7,367
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0I1B

Financial Performance

In 2024, Enovis's revenue was $2.11 billion, an increase of 23.46% compared to the previous year's $1.71 billion. Losses were -$825.49 million, 2381.9% more than in 2023.

Financial numbers in USD